In terms of finding the optimal lifestyle intervention for NAFLD and NASH through DNA methylation, the results determined that repression of mRNA expression of GAB2 in NASH mice models after ELFD intervention could provide an effective treatment strategy for NASH. The gene discussed is GAB2; the disease is metabolic dysfunction-associated steatohepatitis.